A Pilot Study of Neurocysticercosis Treatment

NCT00283699 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Neurocysticercosis

Interventions

DRUG: albendazole
OTHER: placebo

Sponsor

Columbia University

Collaborators

[object Object]